Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer. Clin Genitourin Cancer 2017 Feb;15(1):e95-e97

Date

09/20/2016

Pubmed ID

27641657

DOI

10.1016/j.clgc.2016.08.006

Scopus ID

2-s2.0-84994708562 (requires institutional sign-in at Scopus site)   11 Citations

Author List

Flynn T, Guancial EA, Kilari M, Kilari D

Author

Deepak Kilari MD Associate Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Abiraterone Acetate
Benzamides
Drug Antagonism
Humans
Male
Middle Aged
Neoplasm Metastasis
Nitriles
Phenylthiohydantoin
Prostatic Neoplasms, Castration-Resistant
Spironolactone
Treatment Outcome